Search for: "Sanofi US Services Inc." Results 1 - 20 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2023, 12:00 pm by Bernard Bell
In 1996, HHS issued guidance limiting covered entities to using one contract pharmacy. [read post]
14 Dec 2023, 10:00 pm by Chijioke Okorie
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
26 Jul 2014, 9:14 pm by Mark Summerfield
  Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
AT&T Services, Inc., No. 20-68. [read post]
21 May 2010, 2:32 am by gmlevine
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
17 May 2020, 2:57 am by Anastasiia Kyrylenko
Copyright Eleonora Rosati looked at the role of live streaming providers as ‘online content sharing service providers’ under the DSM Directive. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Finch McCranie, LLP
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
22 May 2020, 6:45 am by Sophie Corke
The Hague Patents Court conducts first virtual hearing in patent case | [Guestpost] Australian government fails to recoup clopidogrel costs from Sanofi | The Bad Spaniel Gets a Treat: VIP Products LLC v Jack Daniels Properties Inc | Does the duration of the storage matter? [read post]
31 Dec 2023, 4:29 pm by Thomas James
Copyright Fair Use Andy Warhol Foundation for the Visual Arts, Inc. v. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]